SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $200,000 | -10.3% | 6,198 | -14.3% | 0.02% | +5.9% |
| Q2 2021 | $223,000 | +10.4% | 7,230 | -6.4% | 0.02% | +6.2% |
| Q1 2021 | $202,000 | -46.3% | 7,727 | -28.0% | 0.02% | -46.7% |
| Q1 2019 | $376,000 | +36.7% | 10,735 | +71.3% | 0.03% | +76.5% |
| Q3 2018 | $275,000 | -69.1% | 6,266 | -57.8% | 0.02% | -68.5% |
| Q2 2018 | $890,000 | +256.0% | 14,863 | +172.7% | 0.05% | +315.4% |
| Q1 2018 | $250,000 | -32.6% | 5,451 | -36.7% | 0.01% | -38.1% |
| Q2 2017 | $371,000 | – | 8,607 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |